CIK 0001901440 · Large accelerated filer
UL Solutions Inc.
Sign in to watch- Ticker
- ULS
- Exchange
- NYSE
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270913800
- Phone
- (847) 272-8800
- Business address
- 333 PFINGSTEN ROAD, NORTHBROOK, IL, 60062
- Former names
- UL Solutions Inc., UL Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,734,738
- in 3 filings, $2.7M under 10b5-1 plans
Net −$2,734,738. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-10 | Hooper Charles W Director | Grant or award · Deferred Restricted Stock Units | +5 | 2,814 | ||
| 2026-09-10 | Hooper Charles W Director | Grant or award · Deferred Restricted Stock Units | +4 | 2,213 | ||
| 2026-09-10 | Hecker Friedrich Director | Grant or award · Restricted Stock Units | +4 | 2,213 | ||
| 2026-09-10 | GOTTSCHALK MARLA C Director | Grant or award · Deferred Restricted Stock Units | +10 | 4,979 | ||
| 2026-09-10 | GOTTSCHALK MARLA C Director | Grant or award · Deferred Restricted Stock Units | +5 | 2,814 | ||
| 2026-09-10 | GOTTSCHALK MARLA C Director | Grant or award · Deferred Restricted Stock Units | +4 | 2,213 | ||
| 2026-09-10 | Genovesi John A See Remarks | Grant or award · Restricted Stock Units | +3 | 1,955 | ||
| 2026-09-10 | Genovesi John A See Remarks | Grant or award · Restricted Stock Units | +5 | 2,718 | ||
| 2026-09-10 | Genovesi John A See Remarks | Grant or award · Restricted Stock Units | +6 | 2,966 | ||
| 2026-09-10 | DOLLIVE JAMES P Director | Grant or award · Restricted Stock Units | +4 | 2,213 | ||
| 2026-09-10 | Dadakis Alex See Remarks | Grant or award · Restricted Stock Units | +21 | 10,727 | ||
| 2026-09-10 | Dadakis Alex See Remarks | Grant or award · Restricted Stock Units | +7 | 3,494 | ||
| 2026-09-10 | Dadakis Alex See Remarks | Grant or award · Restricted Stock Units | +12 | 5,932 | ||
| 2026-09-10 | D'Angelo Scott EVP, CLO & Corporate Secy | Grant or award · Restricted Stock Units | +11 | 5,769 | ||
| 2026-09-10 | D'Angelo Scott EVP, CLO & Corporate Secy | Grant or award · Restricted Stock Units | +4 | 2,403 | ||
| 2026-09-10 | D'Angelo Scott EVP, CLO & Corporate Secy | Grant or award · Restricted Stock Units | +5 | 2,866 | ||
| 2026-09-10 | Chapin Linda S EVP & CHRO | Grant or award · Restricted Stock Units | +2 | 1,468 | ||
| 2026-09-10 | Chapin Linda S EVP & CHRO | Grant or award · Restricted Stock Units | +4 | 2,372 | ||
| 2026-09-10 | Chapin Linda S EVP & CHRO | Grant or award · Restricted Stock Units | +3 | 1,843 | ||
| 2026-09-01 | Scanlon Jennifer F. President and CEO | Sale 10b5-1 | −10,495 | $73.52 | $772K | 141,229 |
Page 3 of 24 · 474 trades